NCT01427335View on ClinicalTrials.gov

Calcium for Prevention of Ovarian Hyperstimulation Syndrome

PHASE3CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

September 30, 2013

Study Completion Date

September 30, 2013

Conditions
Ovarian Hyperstimulation Syndrome
Interventions
DRUG

calcium

"intravenous infusion of 10 % calcium gluconate 10 mL in 200 mL of physiologic saline on the day of ovum pickup, day 1,day 2, and day 3 after ovum pickup were administered in study group.~Intravenous infusion was performed within 30 minutes"

DRUG

0.9 % saline

0.9 % saline intravenous infusion

Trial Locations (1)

12211

Kasr elini hospital, Cairo

All Listed Sponsors
lead

Cairo University

OTHER

NCT01427335 - Calcium for Prevention of Ovarian Hyperstimulation Syndrome | Biotech Hunter | Biotech Hunter